SCHMC

Relationship between group-specific component protein and the development of asthma

Metadata Downloads
Abstract
RATIONALE: Airway inflammation and remodeling during asthma are attributed to the altered expression of biologically relevant proteins. OBJECTIVES: To search for asthma-specific proteins in bronchoalveolar lavage fluid (BAL) from individuals with asthma and to validate the identified proteins in an experimental model of asthma. METHODS: Liquid chromatography-tandem mass spectrometry was performed to identify proteins in BAL fluid found by two dimensional electrophoresis (2DE) to be differentially expressed in subjects with asthma versus control subjects. Group-specific component (Gc) and mRNA levels were measured using an ELISA, Western blots, and PCR. A neutralization study using an antibody against Gc protein was performed in an experimental asthma model. MEASUREMENTS AND MAIN RESULTS: Based on 2DE, 15 proteins were significantly up-regulated or down-regulated in eight subjects with asthma compared with eight control subjects. The protein levels of Gc, hemopexin, and haptoglobin-b were increased, whereas the a1- antitrypsin and glutathione S-transferase levels were decreased in subjects with asthma. The Gc concentration in BAL fluid was significantly elevated in 67 subjects with asthma compared with that in 22 control subjects (P < 0.009). The Gc was significantly correlated with the neutrophil percentage in BAL fluid of subjects with asthma (P = 0.001). Gc mRNA and protein levels were higher in ovalbumin-sensitized/ challenged asthma mice than in sham-treated mice. Gc protein were expressed on alveolar macrophages and on epithelial cells. Treatment with an anti-Gc antibody dose-dependently reduced the ovalbumin sensitization/challenge-induced enhancement of airway hyperreactivity, airway inflammation, goblet cell hyperplasia,and levels of eotaxin, interleukin-4, -5, and -13, and interferon-g. CONCLUSIONS: Gc may be involved in the development of asthma, and the neutralization of Gc protein could be a therapeutic strategy for asthma.
All Author(s)
S. H. Lee ; K. H. Kim ; J. M. Kim ; S. H. Yoon ; T. H. Kim ; S. W. Park ; J. S. Park ; S. T. Uh ; H. S. Lee ; Y. H. Kim
Issued Date
2011
Type
Article
Keyword
asthmaBALGcproteomics2D electrophoresistherapeutic
Publisher
American Thoracic Society
American Lung Association
ISSN
1073-449x
Citation Title
American Journal of Respiratory and Critical Care Medicine
Citation Volume
184
Citation Number
5
Citation Start Page
528
Citation End Page
536
Language(ISO)
eng
DOI
10.1164/rccm.201006-0951OC
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/1204
Appears in Collections:
호흡기내과 > 1. Journal Papers
공개 및 라이선스
  • 공개 구분공개
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.